Delivery Order SPE2DB20D9354-SPE2DB24FX7K5

Award Date 1/19/24
Potential Completion Date 2/9/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products, with a potential value of $149,286.60. The order has a completion date of February 16, 2023 and was awarded on January 26, 2023. DMS Pharmaceutical Group holds a variety of federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and...
This firm fixed price delivery order was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EXPAREL 133 MG/10 ML VIAL 10ML. The order has a potential value of $8,566.92 and a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, with a potential value of $2,291.36. The order has a completion date of February 12, 2024 and was awarded on January 22, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with DLA to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML, with a potential value of $4,974.44 and a completion date of February 2, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drugs to the federal government, particularly...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a potential value of $4,048.12. The delivery order has a completion date of January 19, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML, with a potential value of $9,948.88 and a completion date of January 29, 2024. DMS Pharmaceutical Group holds a variety of federal contracts and indefinite delivery vehicles with DLA to supply pharmaceuticals and medical products in support of military treatment...
The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML. The order, valued at $14,923.32, has a completion date of February 20, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that has been awarded numerous prime and subcontracts by the Department of Veterans Affairs and Department of Defense to provide a wide range of...
This firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the purchase of EXPAREL 266 MG/20 ML VIAL 20ML. The order, valued at $9,948.88, has a completion date of July 25, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA...
The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. This delivery order is valued at $4,974.44 and has a completion date of January 29, 2024. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the Department of Defense and its...
This is a $7,461.66 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, to be delivered by July 15, 2024. DMS Pharmaceutical Group Inc. is the prime contractor and there are no noted subcontractors. This order is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $499,999,999, which allows the DLA to issue...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB24FX7K5
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a potential value of $4,108.20. The completion date for this order is February 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to provide a wide range of pharmaceutical and medical supplies in support of military treatment facilities worldwide.

Generated 4/19/24, 10:00 AM